RxDoctor Payments Data

Christine Ou, DO

Vascular Surgery · Rockingham, VANPI 1851684666

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (57.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $7,681 and has fallen 70.5% since, to $2,263 in 2025.

$14,762in general payments, 2019–2025

Across 112 payments — averaging $131.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Boston Scientific$2K
  • Smith+Nephew$2K
  • Silk Road Medical, Inc.$1K
  • W. L. Gore & Associates, Inc.$195
  • Penumbra, Inc.$166
  • plus $674 from 10 others

What the payments were for

  • Travel & lodging$8,41357%
  • Food & beverage$6,30243%
  • Education$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,762 in reported general payments places this provider in the 65th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$132,722
Medicare patients
613
Services billed
1,478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate188$1,229
Atorvastatin Calcium11$104
Rosuvastatin Calcium11$80
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$45

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Rockingham

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →